Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib

H Mohammad*, K Madsen, O Graumann, A C Loya, N V Jensen, R H Dahlrot

*Corresponding author for this work

Abstract

Metanephric Adenoma (MA) is a rare and unclassifiable renal tumour with sparse reported clinical and morphological features. Generally MA's have a benign course without recurrence after nephrectomy, however a few cases received oncological treatment due to malignant progression. We present a 42-year-old woman who years after an initial nephrectomy developed several processes and biopsy confirmed recurrence of MA. Sunitinib was given for only two weeks, as she developed side-effects and currently the patient undergoes control scans with only minimal growth of the processes. This is the first case of MA treated with Tyrosin-Kinase-Inhibitor.

Original languageEnglish
Article number101880
JournalUrology case reports
Volume40
Pages (from-to)101880
ISSN2214-4420
DOIs
Publication statusPublished - Jan 2022

Fingerprint

Dive into the research topics of 'Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib'. Together they form a unique fingerprint.

Cite this